Project: Better tools for prediction and monitoring of patients’ immune responses for drug development.

Acronym ImmuScreen (Reference Number: 12773)
Duration 15/04/2019 - 16/04/2021
Project Topic We want to develop and validate a Software, called PrDx, to better predict and monitor patient’s immuneresponse to biotherapeutics (protein based therapeutics) and to vaccines. PrDx will complement the biochemical assays and reagents currently commercialized by Immunitrack, and will be key for growth and expansion of the company.
Network Eurostars 2
Call Eurostars Cut–off 10

Project partner

Number Name Role Country
1 Immunitrack ApS Coordinator Denmark
2 Herlev Hospital, at Centre for Cancer Immune Therapy Partner Denmark
3 NOUSCOM Srl Unipersonale Partner Italy